| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/04/2023 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 2.4k | $37.21 | $90.3k | | 01/04/2023 |
| 01/01/2023 | Intellia Therapeutics, Inc. | NTLA | Exercise | Restricted Stock Unit | 3.1k | $0.00 | $0 | | 01/01/2023 |
| 03/01/2022 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (right to buy) | 18.6k | $79.85 | $1.5M | | 03/01/2022 |
| 03/01/2022 | Intellia Therapeutics, Inc. | NTLA | Grant | | 12.7k | $0.00 | $0 | | 01/01/2022 |
| 03/01/2022 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (right to buy) | 12.7k | $79.85 | $1M | | 01/01/2022 |
| 01/01/2022 | Intellia Therapeutics, Inc. | NTLA | Exercise | Restricted Stock Unit | 3.1k | $0.00 | $0 | | 01/01/2022 |
| 01/01/2022 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 1k | $112.24 | $113.7k | | 01/01/2022 |
| 09/07/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 3.5k | $180.12 | $627.2k | | 09/07/2021 |
| 09/07/2021 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 3.5k | $14.58 | $50.8k | | 09/07/2021 |
| 08/31/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 24.8k | $160.22 | $4M | | 08/30/2021 |
| 08/31/2021 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 1.8k | $14.58 | $26.5k | | 08/30/2021 |
| 08/31/2021 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 23k | $19.27 | $442.9k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 5.2k | $19.27 | $100.2k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 300 | $160.84 | $48.3k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 300 | $159.53 | $47.9k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 300 | $158.42 | $47.5k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 496 | $157.33 | $78k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 300 | $156.10 | $46.8k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 1.7k | $155.29 | $264k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 1.1k | $154.29 | $169.7k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 704 | $153.22 | $107.9k | | 08/30/2021 |
| 08/05/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 9.9k | $150.65 | $1.5M | | 08/05/2021 |
| 08/05/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 9.6k | $151.41 | $1.4M | | 08/05/2021 |
| 08/05/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 530 | $152.13 | $80.6k | | 08/05/2021 |
| 08/05/2021 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 20k | $19.27 | $385.4k | | 08/05/2021 |
| 03/03/2021 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (right to buy) | 73.5k | $57.71 | $4.2M | | 03/03/2021 |
| 03/03/2021 | Intellia Therapeutics, Inc. | NTLA | Grant | Restricted Stock Unit | 12.2k | $0.00 | $0 | | 03/03/2021 |
| 03/02/2020 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (Right to Buy) | 125k | $13.40 | $1.7M | | 03/02/2020 |
| 12/18/2018 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (right to buy) | 17.8k | $14.58 | $258.8k | | 12/18/2018 |
| 11/01/2018 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (Right to Buy) | 90k | $19.27 | $1.7M | | 11/01/2018 |
| 11/01/2018 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (Right to Buy) | 90k | $19.27 | $1.7M | | 11/01/2018 |
| 07/23/2015 | AGIOS PHARMACEUTICALS, INC. | AGIO | Sale | Common stock | 7k | $120.45 | $843.2k | | 07/23/2015 |
| 07/23/2015 | AGIOS PHARMACEUTICALS, INC. | AGIO | Exercise | Stock option (right to buy) | 1.3k | $23.10 | $30.5k | | 07/23/2015 |
| 07/23/2015 | AGIOS PHARMACEUTICALS, INC. | AGIO | Exercise | Stock option (right to buy) | 5.7k | $31.64 | $179.7k | | 07/23/2015 |
| 07/17/2015 | AGIOS PHARMACEUTICALS, INC. | AGIO | Sale | Common stock | 13k | $113.71 | $1.5M | | 07/17/2015 |
|